Dyne Roe vs Net Income Per Share Analysis
DYN Stock | USD 31.88 0.68 2.18% |
Dyne TherapeuticsInc financial indicator trend analysis is much more than just examining Dyne TherapeuticsInc latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Dyne TherapeuticsInc is a good investment. Please check the relationship between Dyne TherapeuticsInc Roe and its Net Income Per Share accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.
Roe vs Net Income Per Share
Roe vs Net Income Per Share Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Dyne TherapeuticsInc Roe account and Net Income Per Share. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Dyne TherapeuticsInc's Roe and Net Income Per Share is 0.47. Overlapping area represents the amount of variation of Roe that can explain the historical movement of Net Income Per Share in the same time period over historical financial statements of Dyne TherapeuticsInc, assuming nothing else is changed. The correlation between historical values of Dyne TherapeuticsInc's Roe and Net Income Per Share is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Roe of Dyne TherapeuticsInc are associated (or correlated) with its Net Income Per Share. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income Per Share has no effect on the direction of Roe i.e., Dyne TherapeuticsInc's Roe and Net Income Per Share go up and down completely randomly.
Correlation Coefficient | 0.47 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Roe
Net Income Per Share
Most indicators from Dyne TherapeuticsInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Dyne TherapeuticsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.As of the 2nd of June 2024, Issuance Of Capital Stock is likely to grow to about 126.9 M, while Selling General Administrative is likely to drop about 22 M.
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 1.1M | 1.7M | 1.7M | 997.5K | Research Development | 121.3M | 142.8M | 210.8M | 221.3M |
Dyne TherapeuticsInc fundamental ratios Correlations
Click cells to compare fundamentals
Dyne TherapeuticsInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dyne TherapeuticsInc fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 16.4M | 353.3M | 425.7M | 306.3M | 165.1M | 156.8M | |
Short Long Term Debt Total | 8.4B | 3.4M | 32.6M | 30.5M | 27.4M | 26.0M | |
Other Current Liab | 1.1M | 7.5M | 20.8M | 18.2M | 23.4M | 22.3M | |
Total Current Liabilities | 2.4M | 11.0M | 28.7M | 28.1M | 51.1M | 48.5M | |
Total Stockholder Equity | 14.0M | 342.4M | 368.2M | 252.4M | 91.3M | 86.7M | |
Property Plant And Equipment Net | 1.5M | 1.9M | 41.0M | 38.4M | 33.4M | 31.7M | |
Net Debt | (14.6M) | (300.9M) | (168.2M) | (141.7M) | (94.2M) | (89.5M) | |
Accounts Payable | 1.3M | 3.4M | 4.0M | 5.3M | 22.9M | 21.8M | |
Cash | 14.6M | 300.9M | 200.8M | 172.1M | 121.6M | 115.5M | |
Non Current Assets Total | 1.7M | 8.0M | 43.3M | 50.3M | 35.7M | 33.9M | |
Non Currrent Assets Other | 191K | 3.8M | 2.3M | 9.6M | (1.0) | (0.95) | |
Cash And Short Term Investments | 14.6M | 345.3M | 376.6M | 256.0M | 123.1M | 116.9M | |
Common Stock Shares Outstanding | 45.4M | 14.4M | 50.9M | 52.0M | 59.7M | 56.7M | |
Liabilities And Stockholders Equity | 16.4M | 353.3M | 425.7M | 306.3M | 165.1M | 156.8M | |
Non Current Liabilities Total | 42K | 3.4M | 28.7M | 25.9M | 22.7M | 21.6M | |
Other Current Assets | 127K | 3.8M | 5.8M | 9.6M | 6.3M | 6.0M | |
Other Stockholder Equity | 6.4M | 421.6M | 596.9M | 649.5M | 723.8M | 687.6M | |
Total Liab | 2.4M | 11.0M | 57.5M | 54.0M | 73.8M | 70.1M | |
Property Plant And Equipment Gross | 1.5M | 1.9M | 42.9M | 42.0M | 38.7M | 36.7M | |
Total Current Assets | 14.8M | 345.3M | 382.4M | 256.0M | 129.4M | 122.9M | |
Accumulated Other Comprehensive Income | 0.0 | (27K) | (269K) | (571K) | (656.7K) | (689.5K) | |
Retained Earnings | (19.7M) | (79.2M) | (228.5M) | (396.6M) | (632.5M) | (664.1M) | |
Net Tangible Assets | (13.4M) | 342.4M | 368.2M | 252.4M | 290.2M | 207.8M | |
Net Invested Capital | (13.4M) | 342.4M | 368.2M | 252.4M | 91.3M | 86.7M | |
Net Working Capital | 12.4M | 338.1M | 353.7M | 237.5M | 78.3M | 74.4M | |
Property Plant Equipment | 1.5M | 1.9M | 41.0M | 38.4M | 44.2M | 46.4M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.98) | Return On Assets (0.41) | Return On Equity (0.71) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.